Literature DB >> 3492440

Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation.

M W Böhme, D A Evans, M A Miles, E J Holborow.   

Abstract

Fifteen sera of patients with visceral leishmaniasis were investigated for the occurrence of autoantibodies. They were found in high incidence and titre, and with specificity to the intermediate filament (INFIL) proteins vimentin (12 out of 15 with a titre higher than 1:10) and keratin (9 out of 15 with a titre higher than 1:10) as well as to speckled anti-nuclear antigens (ANA). Additionally, supernatants of Leishmania major and Leishmania donovani cultures containing soluble parasite-derived antigens were mitogenic to cultures of mononuclear cells (MNC) obtained from healthy donors without specific antibodies to leishmanial antigens. The activation of MNC resulted in significant immunoglobulin production, some of which demonstrated autoantibody specificity to INFIL. The co-operation of monocytes, T cells and B cells was required in order to obtain maximal stimulation. The importance of polyclonal B-cell activation for the genesis and occurrence of autoantibodies in visceral leishmaniasis is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492440      PMCID: PMC1453314     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Characterization of the intermediate (10 nm) filaments of cultured cells using an autoimmune rabbit antiserum.

Authors:  W E Gordon; A Bushnell; K Burridge
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  A microplate method of enzyme-linked immunosorbent assay and its application to malaria.

Authors:  A Voller; D Bidwell; G Huldt; E Engvall
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

4.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Leishmanial serotypes as distinguished by the gel diffusion of factors excreted in vitro and in vivo.

Authors:  L F Schnur; A Zuckerman; C L Greenblatt
Journal:  Isr J Med Sci       Date:  1972-07

6.  Enzyme immunoassays for parasitic diseases.

Authors:  A Bartlett; D E Bidwell
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

7.  IgM autoantibody to intermediate filaments in Mycoplasma pneumoniae infections.

Authors:  L Bretherton; B H Toh; I Jack
Journal:  Clin Immunol Immunopathol       Date:  1981-03

8.  A modified 'low pH' lignocaine method to isolate human monocytes: a comparison with other separation procedures.

Authors:  A Zanella; A Mantovani; M Mariani; C Silvani; G Peri; F Tedesco
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments.

Authors:  B H Toh; A Yildiz; J Sotelo; O Osung; E J Holborow; F Kanakoudi; J V Small
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

10.  Coagglutination and indirect hemagglutination in the detection of an excreted immunologically active substance from Leishmania.

Authors:  T Dishon; G M Slutzky; J El-On; C L Greenblatt
Journal:  Isr J Med Sci       Date:  1981-04
View more
  11 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient.

Authors:  Kerstin Amann; Christian Bogdan; Thomas Harrer; Juergen Rech
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

3.  Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection.

Authors:  M W Boehme; P K Kataaha; E J Holborow
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

4.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

6.  Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies.

Authors:  Ricardo Silvestre; Anabela Cordeiro-da-Silva; Joana Tavares; Denis Sereno; Ali Ouaissi
Journal:  Immunology       Date:  2006-10-09       Impact factor: 7.397

7.  Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.

Authors:  A Cordeiro-Da-Silva; M C Borges; E Guilvard; A Ouaissi
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.

Authors:  Y Yang; J Fujita; S Bandoh; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Ishida
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

9.  Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  M A Blaschek; M Boehme; J Jouquan; A M Simitzis; S Fifas; P Le Goff; P Youinou
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

10.  Host Cell Phenotypic Variability Induced by Trypanosomatid-Parasite-Released Immunomodulatory Factors: Physiopathological Implications.

Authors:  Ali Ouaissi; Mehdi Ouaissi; Joana Tavares; Anabela Cordeiro-Da-Silva
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.